Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials

BACKGROUND: Although the US government approved hydroxychloroquine (HCQ) and chloroquine (CQ) for hospitalized coronavirus disease 19 (COVID-19) patients, some studies denied efficacy of HCQ and CQ. We aimed to evaluate HCQ/CQ treatment for COVID-19. METHODS: Five databases were searched on April 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebina-Shibuya, Risa, Namkoong, Ho, Horita, Nobuyuki, Kato, Hideaki, Hara, Yu, Kobayashi, Nobuaki, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867802/
https://www.ncbi.nlm.nih.gov/pubmed/33569200
http://dx.doi.org/10.21037/jtd-20-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867802/
https://www.ncbi.nlm.nih.gov/pubmed/33569200
http://dx.doi.org/10.21037/jtd-20-2022

Ejemplares similares